New Trial Data Show Hair Growth in More Alopecia Areata Patients - Medscape

At 52 weeks, nearly 40% of people taking the higher dose of baricitinib had scalp hair coverage of 80% or more, according to updated clinical trial data.

Nearly 40% of adults with alopecia areata taking baricitinib, an oral Janus kinase (JAK) 1 and 2 inhibitor, see significant hair regrowth over 52 weeks, according to updated results from two phase 3 … [+5115 chars]

full article...